BIOMERICA INC Revenue from Contract with Customer, Excluding Assessed Tax
BIOMERICA INC (BMRA) reported Revenue from Contract with Customer, Excluding Assessed Tax of $4.45 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-31
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for the quarter ending 2026-05-31 was $875.00K, a 16.82% increase year-over-year.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for the quarter ending 2026-02-28 was $987.00K, a 11.80% decline year-over-year.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for the quarter ending 2025-11-30 was $1.21M, a 26.04% decline year-over-year.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for the quarter ending 2025-08-31 was $1.38M, a 23.63% decline year-over-year.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for fiscal 2026 was $4.45M, a 16.16% decline from fiscal 2025.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for fiscal 2025 was $5.31M, a 1.92% decline from fiscal 2024.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for fiscal 2024 was $5.42M, a 1.42% increase from fiscal 2023.
- BIOMERICA INC revenue from contract with customer, excluding assessed tax for fiscal 2023 was $5.34M, a 71.71% decline from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $875.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $1.86M derived: sum of 2 quarters · filed 2026-08-31 | $3.07M derived: sum of 3 quarters · filed 2026-08-31 | $4.45M 10-K · filed 2026-08-31 | |||
| 2026-02-28 | $987.00K 10-Q · filed 2026-04-13 | $2.20M derived: sum of 2 quarters · filed 2026-04-13 | $3.58M 10-Q · filed 2026-04-13 | $4.33M derived: sum of 4 quarters · filed 2026-08-31 | |||
| 2025-11-30 | $1.21M 10-Q · filed 2026-01-14 | $2.59M 10-Q · filed 2026-01-14 | $3.34M derived: sum of 3 quarters · filed 2026-08-31 | $4.46M derived: sum of 4 quarters · filed 2026-08-31 | |||
| 2025-08-31 | $1.38M 10-Q · filed 2025-10-14 | $2.13M derived: sum of 2 quarters · filed 2026-08-31 | $3.25M derived: sum of 3 quarters · filed 2026-08-31 | $4.88M derived: sum of 4 quarters · filed 2026-08-31 | |||
| 2025-05-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $1.87M derived: sum of 2 quarters · filed 2026-08-31 | $3.50M derived: sum of 3 quarters · filed 2026-08-31 | $5.31M 10-K · filed 2026-08-31 | |||
| 2025-02-28 | $1.12M 10-Q · filed 2026-04-13 | $2.75M derived: sum of 2 quarters · filed 2026-04-13 | $4.56M 10-Q · filed 2026-04-13 | $5.68M derived: sum of 4 quarters · filed 2026-04-13 | |||
| 2024-11-30 | $1.64M 10-Q · filed 2026-01-14 | $3.44M 10-Q · filed 2026-01-14 | $4.56M derived: sum of 3 quarters · filed 2026-01-14 | $5.58M derived: sum of 4 quarters · filed 2026-01-14 | |||
| 2024-08-31 | $1.81M 10-Q · filed 2025-10-14 | $2.92M derived: sum of 2 quarters · filed 2025-10-14 | $3.94M derived: sum of 3 quarters · filed 2025-10-14 | $5.51M derived: sum of 4 quarters · filed 2025-10-14 | |||
| 2024-05-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $2.13M derived: sum of 2 quarters · filed 2025-08-29 | $3.70M derived: sum of 3 quarters · filed 2025-08-29 | $5.42M 10-K · filed 2025-08-29 | |||
| 2024-02-29 | $1.02M 10-Q · filed 2025-04-14 | $2.58M derived: sum of 2 quarters · filed 2025-04-14 | $4.30M 10-Q · filed 2025-04-14 | $5.41M derived: sum of 4 quarters · filed 2025-04-14 | |||
| 2023-11-30 | $1.57M 10-Q · filed 2025-01-14 | $3.28M 10-Q · filed 2025-01-14 | $4.39M derived: sum of 3 quarters · filed 2025-01-14 | $5.50M derived: sum of 4 quarters · filed 2025-01-14 | |||
| 2023-08-31 | $1.71M 10-Q · filed 2024-10-15 | $2.82M derived: sum of 2 quarters · filed 2024-10-15 | $3.93M derived: sum of 3 quarters · filed 2024-10-15 | $5.41M derived: sum of 4 quarters · filed 2024-10-15 | |||
| 2023-05-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $2.22M derived: sum of 2 quarters · filed 2024-08-28 | $3.70M derived: sum of 3 quarters · filed 2024-08-28 | $5.34M 10-K · filed 2024-08-28 | |||
| 2023-02-28 | $1.11M 10-Q · filed 2024-04-12 | $1.11M 10-Q · filed 2023-04-14 | $2.59M derived: sum of 2 quarters · filed 2024-04-12 | $4.23M 10-Q · filed 2024-04-12 | $9.53M derived: sum of 4 quarters · filed 2024-04-12 | ||
| 2022-11-30 | $1.48M 10-Q · filed 2024-01-16 | $3.12M 10-Q · filed 2024-01-16 | $8.42M derived: sum of 3 quarters · filed 2024-01-16 | $16.08M derived: sum of 4 quarters · filed 2024-01-16 | |||
| 2022-08-31 | $1.64M 10-Q · filed 2023-10-12 | $6.94M derived: sum of 2 quarters · filed 2023-10-12 | $14.60M derived: sum of 3 quarters · filed 2023-10-12 | $19.25M derived: sum of 4 quarters · filed 2023-10-12 | |||
| 2022-05-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | $12.96M derived: sum of 2 quarters · filed 2023-08-25 | $17.61M derived: sum of 3 quarters · filed 2023-08-25 | $18.87M 10-K · filed 2023-08-25 | |||
| 2022-02-28 | $7.66M 10-Q · filed 2023-04-14 | $12.31M derived: sum of 2 quarters · filed 2023-04-14 | $13.57M 10-Q · filed 2023-04-14 | $14.62M derived: sum of 4 quarters · filed 2023-04-14 | |||
| 2021-11-30 | $4.65M 10-Q · filed 2023-01-13 | $5.91M 10-Q · filed 2023-01-13 | $6.96M derived: sum of 3 quarters · filed 2023-01-13 | $10.59M derived: sum of 4 quarters · filed 2023-01-13 | |||
| 2021-08-31 | $1.26M 10-Q · filed 2022-10-13 | $2.32M derived: sum of 2 quarters · filed 2022-10-13 | $5.95M derived: sum of 3 quarters · filed 2022-10-13 | $7.32M derived: sum of 4 quarters · filed 2022-10-13 | |||
| 2021-05-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-29 | $4.68M derived: sum of 2 quarters · filed 2022-08-29 | $6.06M derived: sum of 3 quarters · filed 2022-08-29 | $7.20M 10-K · filed 2022-08-29 | |||
| 2021-02-28 | $3.63M 10-Q · filed 2022-04-14 | $5.00M derived: sum of 2 quarters · filed 2022-04-14 | $6.14M 10-Q · filed 2022-04-14 | $8.87M derived: sum of 4 quarters · filed 2022-04-14 | |||
| 2020-11-30 | $1.37M 10-Q · filed 2022-01-12 | $1.37M 10-Q · filed 2021-01-14 | $2.52M 10-Q · filed 2022-01-12 | $2.52M 10-Q · filed 2021-01-14 | $5.24M derived: sum of 3 quarters · filed 2022-01-12 | $6.42M derived: sum of 4 quarters · filed 2022-01-12 | |
| 2020-08-31 | $1.14M 10-Q · filed 2021-10-14 | $1.14M 10-Q · filed 2020-10-15 | $3.87M derived: sum of 2 quarters · filed 2021-10-14 | $5.05M derived: sum of 3 quarters · filed 2021-10-14 | $6.64M derived: sum of 4 quarters · filed 2021-10-14 | ||
| 2020-05-31 | $2.73M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14 | $3.90M derived: sum of 2 quarters · filed 2021-10-14 | $5.50M derived: sum of 3 quarters · filed 2021-10-14 | $6.69M 10-K/A · filed 2021-10-14 | $6.69M 10-K · filed 2020-08-31 | ||
| 2020-02-29 | $1.18M 10-Q · filed 2021-04-14 | $2.77M derived: sum of 2 quarters · filed 2021-04-14 | $3.97M 10-Q · filed 2021-04-14 | $5.13M derived: sum of 4 quarters · filed 2021-04-14 | |||
| 2019-11-30 | $1.60M 10-Q · filed 2021-01-14 | $2.79M 10-Q · filed 2021-01-14 | $3.96M derived: sum of 3 quarters · filed 2021-01-14 | $5.22M derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | $1.19M 10-Q · filed 2020-10-15 | $2.36M derived: sum of 2 quarters · filed 2020-10-15 | $3.62M derived: sum of 3 quarters · filed 2020-10-15 | ||||
| 2019-05-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31 | $2.43M derived: sum of 2 quarters · filed 2020-08-31 | $5.20M 10-K · filed 2020-08-31 | ||||
| 2019-02-28 | $1.26M 10-Q · filed 2020-04-14 | $4.04M 10-Q · filed 2020-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |